Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2928438 | Indian Pacing and Electrophysiology Journal | 2014 | 5 Pages |
Abstract
New devices designed for minimally invasive closure of the left atrial appendage (LAA) may be a viable alternative for patients in whom anticoagulation is considered high risk. The Lariat (Sentreheart, Redwood City, CA), which is currently FDA-approved for percutaneous closure of tissue, requires both trans-septal puncture and epicardial access. However it requires no anticoagulation after the procedure. Here we describe a case of effusion and tamponade during a Lariat procedure with successful completion of the case and resolution of the effusion.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Amena Hussain, Muhamed Saric, Scott Bernstein, Douglas Holmes, Larry Chinitz,